EGFR and non-small cell lung carcinoma: While there is limited research on CRC TAM-secreted growth factors and EGFR mAb resistance, it has been suggested that macrophage-derived EREG may play a role in EGFR-targeted inhibitor resistance in non-small cell lung cancer (NSCLC) [97].